Amyloid Beta Dynamics in Biological Fluids-Therapeutic Impact.

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Alzheimer's disease (AD) poses significant individual and socioeconomic burdens.
• Current AD treatments are inadequate, necessitating novel therapeutic strategies.
• The amyloidogenic pathway, involving beta-amyloid (Aβ), remains a key focus in AD research.

Purpose of the Study:

• To provide insights into beta-amyloid (Aβ), a critical biomarker in Alzheimer's disease.
• To detail Aβ structure, function, and dynamics in normal and pathological states.
• To review Aβ elimination mechanisms within the central nervous system (CNS) and therapeutic approaches.

Main Methods:

• Literature review focusing on Aβ structure, function, and metabolism.
• Analysis of Aβ dynamics across biological compartments.
• Examination of CNS Aβ clearance pathways, including blood-brain barrier transport.
• Review of existing and emerging therapeutic strategies for Aβ elimination.

Main Results:

• Aβ structure and function are detailed in both healthy and diseased conditions.
• Aβ dynamics are explored across various biological compartments.
• Blood-brain barrier clearance is identified as a dominant Aβ elimination route from the CNS.
• Therapeutic strategies like peripheral and cerebrospinal fluid sinks are presented.

Conclusions:

• Stimulating Aβ clearance, particularly from the cerebrospinal fluid, is crucial for AD treatment.
• A multidisciplinary approach is necessary to enhance Aβ elimination from the CNS.
• Further research into novel Aβ clearance mechanisms holds promise for future AD therapies.